antibodies to the antigens were observed among 21 of 24 ( 87 percent ) cervical cancer cases , 44 of 49 ( 90 percent ) laryngeal cancer cases , 15 of 24 ( 62 percent ) cases of squamous cell carcinomas of the head and neck excluding the larynx , 2 of 24 ( 8 percent ) nonsquamous cell cancer cases , and 3 of 51 ( 6 percent ) normal subjects .
C0007107
laryngeal cancer
C0023078
larynx